Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair.
暂无分享,去创建一个
[1] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[2] K. Tobita,et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. , 2009, Biomaterials.
[3] Xian‐Zheng Zhang,et al. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. , 2009, Journal of biomedical materials research. Part A.
[4] Tong Hao,et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.
[5] Randall J. Lee,et al. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. , 2009, Biomaterials.
[6] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[7] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[8] Xian‐Zheng Zhang,et al. Novel thermosensitive hydrogel injection inhibits post‐infarct ventricle remodelling , 2009, European journal of heart failure.
[9] Julie A. Phillippi,et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. , 2008, Journal of the American College of Cardiology.
[10] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[11] R. Guyton,et al. Abstract 1847: Modulation of Cardiac Remodeling with Acellular Matrix Emulsion is Associated with Myofibroblast Proliferation and Angiogenesis via Recruiting C-Kit Positive Cells after Myocardial Infarction , 2008 .
[12] S. Berceli,et al. 071 Connective Tissue Growth Factor (CTGF) Content and Bioactivity of Small Intestinal Submucosa (SIS) , 2008 .
[13] Smadar Cohen,et al. Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat , 2008, Circulation.
[14] Stephen F Badylak,et al. The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.
[15] David J Mooney,et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.
[16] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.
[17] Randall J Lee,et al. Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.
[18] Richard T. Lee,et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.
[19] Johnny Huard,et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] N. Smedira,et al. Small Intestinal Submucosa Intracardiac Patch: An Experimental Study , 2005, Surgical innovation.
[21] Theo Kofidis,et al. Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.
[22] K. Christman,et al. Pleiotrophin induces formation of functional neovasculature in vivo. , 2005, Biochemical and biophysical research communications.
[23] S. Badylak,et al. Extracellular matrix for myocardial repair. , 2005, The heart surgery forum.
[24] Richard T. Lee,et al. Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.
[25] Ching-Pin Chang,et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. , 2004, The Journal of thoracic and cardiovascular surgery.
[26] Randall J Lee,et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.
[27] Randall J Lee,et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.
[28] J. Schalken,et al. A rabbit model to tissue engineer the bladder. , 2004, Biomaterials.
[29] Masashi Komeda,et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model , 2003, Heart and Vessels.
[30] S. Badylak,et al. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. , 2002, Biomaterials.
[31] Jason Hodde,et al. Naturally occurring scaffolds for soft tissue repair and regeneration. , 2002, Tissue engineering.
[32] Dusan Pavcnik,et al. Percutaneous bioprosthetic venous valve: a long-term study in sheep. , 2002, Journal of vascular surgery.
[33] N. Sharpe,et al. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.
[34] E. Cheng,et al. Urologic tissue engineering with small-intestinal submucosa: potential clinical applications , 2000, World Journal of Urology.
[35] S. Badylak,et al. Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold. , 1999, Biomaterials.
[36] S. Badylak,et al. Identification of extractable growth factors from small intestinal submucosa , 1997, Journal of cellular biochemistry.
[37] L A Geddes,et al. Small intestinal submucosa as a large diameter vascular graft in the dog. , 1989, The Journal of surgical research.
[38] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[39] J. Leor,et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. , 2009, Biomaterials.
[40] M. Chancellor,et al. Advances toward tissue engineering for the treatment of stress urinary incontinence. , 2004, Reviews in urology.